Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub

Coronavirus disease 2019 (COVID-19) is an illness resulting from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that emerged in late 2019. Patients with cancer, and especially those with hematologic malignancies, may be at especially high risk of adverse outcomes, including mortality r...

Descripción completa

Detalles Bibliográficos
Autores principales: Wood, William A., Neuberg, Donna S., Thompson, J. Colton, Tallman, Martin S., Sekeres, Mikkael A., Sehn, Laurie H., Anderson, Kenneth C., Goldberg, Aaron D., Pennell, Nathan A., Niemeyer, Charlotte M., Tucker, Emily, Hewitt, Kathleen, Plovnick, Robert M., Hicks, Lisa K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
Health Services and Outcomes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724912/
https://www.ncbi.nlm.nih.gov/pubmed/33278301
http://dx.doi.org/10.1182/bloodadvances.2020003170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724912/
https://www.ncbi.nlm.nih.gov/pubmed/33278301
http://dx.doi.org/10.1182/bloodadvances.2020003170

Ejemplares similares